We help people hear and be heard. We empower people to connect with others and live a full life.
We help transform the way people understand and treat hearing loss.
We innovate and bring to market a range of implantable hearing solutions that deliver a lifetime of hearing outcomes.
Cochlear commenced operations in 1981 as part of the Nucleus group. In 1995, the company listed on the Australian Securities Exchange. Today, it is a global company with principal manufacturing facilities in Australia and Sweden, and additional manufacturing facilities in Belgium and the United States. Cochlear has its global headquarters on campus at Macquarie University in Sydney, Australia, with regional headquarters in Asia Pacific, Europe and the Americas. Cochlear has direct operations in 20 countries and 2,700 employees.
Cochlear develops a range of products including cochlear implants, bone conduction implants and acoustic implants, which address different types of hearing loss. Whether these hearing solutions were implanted today or many years ago, Cochlear guarantees that new technologies and innovations are available to its recipients. The company invests more than AUS$100 million each year in research and development and currently participates in over 100 collaborative research programs worldwide.
Over 350,000 people of all ages, across more than 100 countries, now hear because of Cochlear.
Cochlear’s promise is ‘Hear now. And always’ – to provide recipients with the best possible hearing and support for the rest of their lives.
Entellus Medical™ is a medical technology company focused on the design, development and commercialization of products for the minimally invasive treatment of chronic and recurrent sinusitis patients in the physician office setting or operating room. Its XprESS™ family of products is used by ENT physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation. When used as a stand-alone therapy, Entellus Medical’s balloon sinus dilation products are the only devices proven in a sufficiently powered prospective, multicenter, randomized, controlled trial to be as effective as functional endoscopic sinus surgery, or FESS. Patients treated with Entellus Medical’s products in this trial in the ENT physician office also experienced faster recovery, less bleeding at discharge, less use of prescription pain medication and fewer post-procedure debridements than patients receiving FESS.
At Olympus, we work with health care professionals every day, matching our innovative capabilities in medical technology and precision manufacturing with their skills to provide the best possible outcomes for patients and society. As the healthcare industry focuses on early detection of diseases and minimally invasive procedures, Olympus is there to deliver the diagnostic and therapeutic technologies they need to treat their patients Olympus provides a broad line of products for the total ENT community. At this year’s 3rd Congress of EAORL-HNS, Olympus introduces several new products to the ENT market which will be displayed in our booth.
KARL STORZ is a renowned manufacturer that is well established in all fields of endoscopy and can be considered as market leader in rigid endoscopy. The still family held company was founded in 1945 in Tuttlingen, Germany, and has grown to one with a worldwide presence and 6700 employees. KARL STORZ offers a range of both rigid and flexible endoscopes for a broad variety of applications. Today’s product range also includes fully integrated concepts for the OR and servicing.
Innovating for life
At Medtronic, we’re changing what it means to live with chronic disease. We’re creating innovative therapies that help patients do things they never thought possible. Seeing our work improve lives is a powerful motivator. The more we do, the more we’re driven to push the boundaries of medical technology.
We established our company in 1992 with the aim to trade in spare parts, motor oils and tires for passenger cars and lorry vehicles. We have been extending our business step by step and we started to trade in other components as garden machinery, internal and international traffic and since 1994 licensed selling and service of lorry vehicles (Nissan). We gained licence for selling passenger cars of the same brand in 2004. The company has become one of the three most successful Nissan dealers in the Czech Republic and was awarded as the best Nissan dealer in the Czech Republic in the years 2012 and 2013. We believe we will continue in this success.
For more than 20 years Spiggle & Theis is an international company specializing in otolaryngology and head and neck surgery. These include over 2400 special instruments as well as a wide range of disposables. As a company, a manufacturer and service provider in the field of medical technology, we are committed to the quality of our products, the welfare of the patient and the support of the physician. We see our role as a partner for our customers and are always willing to listen to and understand their needs.
We are continually increasing our product range and are always on the lookout for new ideas, technologies and innovative products. Close contact to the surgeons is vital as they generate the most ideas due to daily practice. Export business is extremely important for us and plays a vital role in our growth strategy.
Auris Medical is a Swiss biopharmaceutical company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology. The Company is currently focusing on the development of treatments for acute inner ear tinnitus (AM-101) and for acute inner ear hearing loss (AM-111) by way of intratympanic injection with biocompatible gel formulations. A large phase 3 clinical programme with AM-101was initiated in 2014, involving more than 120 clinical sites world-wide. In addition, a phase 3 clinical trial with AM-111 is currently under preparation. The Company was founded in 2003.
A global pioneer in medical breakthroughs, Cook Medical is committed to creating effective solutions that benefit millions of patients worldwide. Today, we combine medical devices, drugs, biologic grafts and cell therapies across more than 16,000 products serving more than 40 medical specialties. Founded in 1963 by a visionary who put patient needs and ethical business practices first, Cook is a family-owned company that has created more than 10,000 jobs worldwide. Follow Cook Medical on Twitter @cookmedical
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies.
For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. We have pioneered innovations such as the CO2 medical laser and lead the next-generation ENT treatments, empowering surgeons with ultimate accuracy and superior clinical outcomes.
Lumenis is an agent of change enabling adoption of minimally invasive procedures driven by a growing aging population.
MED-EL is a leading provider of hearing implant systems worldwide. The company was founded by Austrian scientists and industry pioneers Ingeborg and Erwin Hochmair in 1990 and now has more than 1500 employees.
Today, MED-EL offers the widest range of implantable hearing solutions to treat the various degrees of hearing loss, including cochlear, middle ear, and bone conduction implant systems as well as a system for combined electric and acoustic stimulation, and an auditory brainstem implant.
MED-EL’s mission is to overcome hearing loss as a barrier to communication and quality of life. Individuals in approximately 100 countries enjoy the gift of hearing with a MED-EL Hearing Implant System.
SinuSys Corp. strives to improve the health of patients worldwide through the development and commercialization of the Vent-Os® Sinus Dilation System, the Restora™ drug delivery technology, and other osmotic and rate-controlled therapies for serious ear, nose and throat conditions.
Smith & Nephew’s unique COBLATION™ technology has procedural focus in Tonsils, Adenoids, Sinus and Sleep related conditions. New innovations for surgery include the ENTACT™ septal stapler, SERPENT™ articulating instruments for sinus surgery and MEDIENT™ middle turbinate implant, designed to prevent middle turbinate lateralization.
The main activities of the Carl Zeiss Meditec AG, parent company of the Carl Zeiss Meditec Group, are located in the field of ophthalmology and microsurgery. The company is listed on TecDAX of the German stock exchange.
Carl Zeiss Meditec AG supplies and provides
- innovative technologies and application-oriented solutions designed to help doctors improve their patients' quality of life
- complete packages of solutions for the diagnosis and treatment of ophthalmic diseases, including implants and consumables
- innovative visualization solutions in the field of microsurgery
- promising, future-oriented technologies such as intraoperative radiotherapy.
Worldwide neurosurgeons as well as ear, nose and throat specialist and ophthalmologists put their trust in the know-how of ZEISS.